Form D · Biotechnology
Fe3 Medical, Inc.
San Antonio, TX · CIK 0001503239
Offering snapshot reported Jan 11, 2011 · SEC filing
- Reported sold
- $3.99M Offering amount: $8M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 28, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 11, 2011 | Initial | $3,988,958 | No comparison | 8 | SEC filing |
| Oct 18, 2010 | Initial | $1,420,500 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-153477
$3,488,958.00 issued upon conversion of the principal and unaccrued unpaid interest under outstanding convertible promissory notes issued by the Issuer.
Source: Form D, filed Jan 11, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ron Berenson | Director |
| Mir A. Imran | Director, Executive |
| Wayne Roe | Director |
| Syed Zaidi | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12500 Network Blvd. Suite #112
San Antonio, TX, 78249
San Antonio, TX, 78249